[go: up one dir, main page]

PT1001789E - A compound comprising at least one double-celled RNA in an association with at least one derivative of 6-benzyluronyl for simultaneous or delayed use of the same or different - Google Patents

A compound comprising at least one double-celled RNA in an association with at least one derivative of 6-benzyluronyl for simultaneous or delayed use of the same or different

Info

Publication number
PT1001789E
PT1001789E PT98941526T PT98941526T PT1001789E PT 1001789 E PT1001789 E PT 1001789E PT 98941526 T PT98941526 T PT 98941526T PT 98941526 T PT98941526 T PT 98941526T PT 1001789 E PT1001789 E PT 1001789E
Authority
PT
Portugal
Prior art keywords
derivative
benzyluronyl
double
simultaneous
association
Prior art date
Application number
PT98941526T
Other languages
Portuguese (pt)
Inventor
Eric Ruhlmann
Original Assignee
Cons De Rech Et D Applica Scie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cons De Rech Et D Applica Scie filed Critical Cons De Rech Et D Applica Scie
Publication of PT1001789E publication Critical patent/PT1001789E/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention concerns a product comprising at least a double stranded RNA combined with at least a 6-benzyluracil derivative to be used in therapy simultaneously, separately or spread over time. Said product can be optionally combined with another antiviral agent. Said products are particularly useful for treating AIDS (Acquired Immuno Deficiency Syndrome).
PT98941526T 1997-08-04 1998-08-03 A compound comprising at least one double-celled RNA in an association with at least one derivative of 6-benzyluronyl for simultaneous or delayed use of the same or different PT1001789E (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9709974A FR2766711B1 (en) 1997-08-04 1997-08-04 PRODUCT COMPRISING AT LEAST ONE DOUBLE-STRANDED RNA IN ASSOCIATION WITH AT LEAST ONE DEVIRE OF 6-BENZYLURACIL FOR SIMULTANEOUS THERAPEUTIC USE, SEPARATE OR SPREAD OVER TIME

Publications (1)

Publication Number Publication Date
PT1001789E true PT1001789E (en) 2003-03-31

Family

ID=9510012

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98941526T PT1001789E (en) 1997-08-04 1998-08-03 A compound comprising at least one double-celled RNA in an association with at least one derivative of 6-benzyluronyl for simultaneous or delayed use of the same or different

Country Status (10)

Country Link
EP (1) EP1001789B1 (en)
AT (1) ATE227132T1 (en)
AU (1) AU8987198A (en)
DE (1) DE69809246T2 (en)
DK (1) DK1001789T3 (en)
ES (1) ES2187056T3 (en)
FR (1) FR2766711B1 (en)
NO (1) NO20000554D0 (en)
PT (1) PT1001789E (en)
WO (1) WO1999007384A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases

Also Published As

Publication number Publication date
ATE227132T1 (en) 2002-11-15
DK1001789T3 (en) 2003-03-10
FR2766711B1 (en) 2001-02-02
FR2766711A1 (en) 1999-02-05
DE69809246T2 (en) 2003-08-28
WO1999007384A1 (en) 1999-02-18
AU8987198A (en) 1999-03-01
DE69809246D1 (en) 2002-12-12
EP1001789A1 (en) 2000-05-24
EP1001789B1 (en) 2002-11-06
ES2187056T3 (en) 2003-05-16
NO20000554L (en) 2000-02-03
NO20000554D0 (en) 2000-02-03

Similar Documents

Publication Publication Date Title
ES2171039T3 (en) PRODUCT THAT INCLUDES AT LEAST A double-stranded RNA IN ASSOCIATION WITH AT LEAST ONE INTERFER FOR THE TREATMENT OF VIRAL HEPATITIS.
CY1119742T1 (en) BIOLOGICAL INTERFERENCE-INGREDIENT TRANSPORT SYSTEMS
TR200002355T2 (en) 2- (Purin-9-yl) tetrahydrofuran-3,4-diol derivatives
ES2184149T3 (en) PACLITAXELES 6-UNCLE SUBSTITUTED.
BG46598A3 (en) METHOD FOR OBTAINING ALPHA-HETEROCYCLIC SUBSTITUTED TOLUNITRILE
WO2004007743A3 (en) Use of cpg nucleic acids in prion-disease
DE69811062D1 (en) POLYAROMATIC ANTIVIRAL COMPOSITIONS
TR200003513T2 (en) Pirolo [2,3d] Pyrimidine compositions and uses
BG103251A (en) OXADIDASOLS, METHODS FOR THEIR RECEIVING AND THEIR USE AS MEDICINES
TR199903331T2 (en) Farnesil protein transferase inhibitors.
ATE180776T1 (en) NAPHTHYL COMPOUNDS, INTERMEDIATE PRODUCTS, COMPOSITIONS AND METHODS
ATE231872T1 (en) THIAZOLOPYRIMIDE DERIVATIVES
AU1565300A (en) Anti-germinating method for tubers and bulbs using eugenol and/or isoeugenol
ATE275956T1 (en) ALTERATION OF DNA METHYLTRANSFERASE THROUGH COMBINATION THERAPY
PL322681A1 (en) Cytostatic agents modified with carbohydrates
SE9604348D0 (en) Use of hydroxyguanidines
DK0869965T3 (en) Steroid nitrite ester derivatives useful as anti-inflammatory drugs
ES2195655T3 (en) PROCEDURE TO TREAT VIRIC HEMORRAGICAL FEVER WITH PROTEIN C.
AU1192397A (en) Substituted thiazolines and their use for controlling animal pests
PT1001789E (en) A compound comprising at least one double-celled RNA in an association with at least one derivative of 6-benzyluronyl for simultaneous or delayed use of the same or different
IT1289154B1 (en) ISOFLAVONE DERIVATIVES THEIR PREPARATION AND THEIR THERAPEUTIC USE
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
HUP0002826A3 (en) 6-azauracil derivatives, process for producing them, their use for producing medicament useful against inflammatory diseases and such compositions
PT1011329E (en) 7-METHYLTHYOXXYETHYL AND 7-METHYLTHYDROXYETHYL PACLITAXES
AU4511299A (en) Imidazotriazolopyrimidines used as a drug having an adenosine antagonist activity